This site is new - feedback and suggestions welcome via GitHub issues.

#clinical trial — Saturday, February 07, 2026 (3 items)

hot top new auto
← prev day next day →
0 ℹ Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trial. (linkinghub.elsevier.com) robot Colson AE … Lahoulou R The Lancet 2026-02-07 #amr #clinical trial #hiv
0 ℹ Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial. (linkinghub.elsevier.com) robot Orkin C … Kim J The Lancet 2026-02-07 #amr #clinical trial #hiv #virologic suppression
0 ℹ TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198. (linkinghub.elsevier.com) robot Trachtman H … Soleymanlou N The Lancet 2026-02-07 #clinical trial #proteinuria #fsgs #podocyte #trpc6